Chemical and physical restraint of nonhuman primates.
Numerous publications on primate restraint and anesthesiology have appeared in recent years. This reflects the striking growth of interest in medical primatology and of efforts to improve restraint agents and methods to facilitate humane use of primates in research. For access to earlier literature, readers should consult recent textbooks [12; 29, pp. 469--474], reviews on chemical or physical restraint [3, 4, 16, 27, 30, 37], and other valuable publications on these subjects that have appeared since 1965 [1, 20, 23, 36, 40, 42]. In this brief review we consider publications, principally since 1971, that deal with chemical or physical restraint. We also present previously unpublished data on the clinical use in primates of CI 744 (Telazol), a new dissociative anesthetic that until recently has been available only for investigational use.
D000530:Alfaxalone Alfadolone Mixture / Q000494:pharmacology; D000777:Anesthetics; D000778:Anesthetics, Dissociative / Q000494:pharmacology; D000818:Animals; D004338:Drug Combinations; D006221:Halothane / Q000494:pharmacology; D000882:Haplorhini; D007103:Immobilization; D007649:Ketamine / Q000494:pharmacology; D008251:Macaca; D008723:Methohexital / Q000494:pharmacology; D008733:Methoxyflurane / Q000494:pharmacology; D011323:Primates / Q000502:physiology*; D012149:Restraint, Physical / Q000662:veterinary; D013390:Succinylcholine / Q000494:pharmacology; D013992:Tiletamine / Q000494:pharmacology; D014991:Xylazine / Q000494:pharmacology; D015041:Zolazepam / Q000494:pharmacology
D000777:Anesthetics; D000778:Anesthetics, Dissociative; D004338:Drug Combinations; C006131:tiletamine, zolazepam drug combination; D014991:Xylazine; D013992:Tiletamine; D008733:Methoxyflurane; D007649:Ketamine; D000530:Alfaxalone Alfadolone Mixture; D008723:Methohexital; D015041:Zolazepam; D013390:Succinylcholine; D006221:Halothane